University Startup PvP Biologics Acquired by Takeda Pharmaceutical Company
PvP Biologics, born from collaboration between the University of Washington and UC Davis, has been acquired by Takeda Pharmaceutical. Their enzyme-based treatment for celiac disease, TAK-062, shows promise after successful...